Always verify pricing and state availability on the provider's website before signing up.How our reviews work →

altRX vs MEDVi

In our scoring, altRX edges ahead overall (7.4 vs 7.1 out of 10), and altRX costs less for compounded semaglutide (about $2,520 a year less).

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

By Eli Marsden · Founding Editor
Editorially reviewed & fact-checked against primary sources · How we verify contentLast reviewed

Key differences

Price
altRX $89/mo vs MEDVi $299/mo for compounded semaglutide (standing prices, no prepay or separate membership listed · about $2,520 a year less with altRX)
Coverage
MEDVi 48 states (altRX doesn't publish a state list)
Included
altRX: medication, clinician visits, shipping; MEDVi: medication, clinician visits, shipping, coaching

How we compare providers

altRX logo

altRX

Affiliate partner

Best for low-cost compounded GLP-1s with brand-name Zepbound, Wegovy and Ozempic as options

semaglutide

$89/mo

Our score 7.4/10

MEDVi logo

MEDVi

Affiliate partner

Best for switching between compounded and brand-name GLP-1 through one provider

semaglutide

$299/mo

$179 first month

Our score 7.1/10

We may earn a commission if you sign up through these links. Partner status can affect which provider we feature; it never changes a score or a price.

Costs & coverage

Published prices with their terms attached. Yearly figures are modeled from the standing price and billing cadence. A check mark marks the better side, on like-for-like rows only.

altRX

MEDVi

Price

Semaglutide / month

Better on this row: $89/mo

$299/mo

$179 first month

Semaglutide / year (modeled)

Better on this row: $1,068

$3,588

Tirzepatide / month

$149/mo

Not listed

Oral semaglutide / month

Not listed

$249/mo

Brand Wegovy / Ozempic / month

$1,149/mo

Not listed

Brand Zepbound / Mounjaro / month

$1,249/mo

Not listed

Coverage

State availability

List not published

48 states

Oral option listed

Not listed

Yes

Brand-name access listed

Wegovy / Ozempic, Zepbound / Mounjaro

Not listed

Included in the price

Medication, clinician visits, shipping

Medication, clinician visits, shipping, coaching

Terms & safety

Price shown

Before intake

Before intake

Lab work

Not disclosed

Not required

Video visit

Not disclosed

Not required

Cancel anytime

Yes

Not disclosed

Minimum commitment

Single-month and multi-month plans; multi-month plans are a single, non-refundable purchase for the full term

Membership

Refunds

Refund policy (Aug 25, 2026): 'ALL PAYMENTS FOR THE SUBSCRIPTION SERVICES ARE FINAL AND NON-REFUNDABLE AT THE TIME OF PURCHASE.' A medical disqualification refunds the unused portion minus consultations, provider review and other services already rendered.

Not disclosed

FDA warning letters

1 warning letter

1 warning letter

Provider facts checked

October 2026

August 2026

Every dose and plan: altRX · MEDVi

Get alerted when GLP-1 prices drop

Join the GLP-1 price-watch list — we re-verify 540+ providers' prices on their own sites and email you when tracked prices move.

Which fits your priorities?

Only the points where these two differ, from the table above and each provider’s record.

altRX logo

Choose altRX if…

  • About $2,520 a year less than MEDVi for compounded semaglutide at standing prices
  • Lists compounded tirzepatide, brand-name Wegovy / Ozempic and brand-name Zepbound / Mounjaro, which MEDVi doesn't price
  • Brand-name Zepbound, Wegovy and Ozempic available alongside compounded options

What to weigh up

  • 1 FDA warning letter on record
  • No published state list; confirm yours at signup
MEDVi logo

Choose MEDVi if…

  • Lists oral compounded semaglutide, which altRX doesn't price
  • Publishes its full state list (48 states)
  • Both compounded and brand-name (Wegovy, Zepbound) GLP-1 options in one platform

What to weigh up

  • 1 FDA warning letter on record
  • About $2,520 a year more than altRX for compounded semaglutide

Explore the scoring factors

Both providers are scored on the same six-dimension framework. The gradient bar marks the stronger side on each dimension.

altRX

7.4/10

Overall

MEDVi

7.1/10

Value25%

7.5A
vs
B
6.0

Effectiveness25%

8.0A
vs
B
8.0

User Experience15%

7.0A
vs
B
7.5

Trust & Safety15%

6.8A
vs
B
6.8

Accessibility10%

7.0A
vs
B
8.0

Support10%

7.4A
vs
B
7.0

Ready to start? Vetted GLP-1 providers

Vetted telehealth providers that prescribe GLP-1 online.

No insurance needed · vetted by our editors

WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more

7.2

Willow

Needle-free compounded semaglutide or tirzepatide tablets

Read full review →

From $299/mo

Get started →
7.6

SkinnyRx

Compounded semaglutide or tirzepatide with the consult and free overnight shipping in one price

Read full review →

From $149.25/mo

Get started →
8.3

Collective

The lowest flat medication price if you can absorb an annual membership fee

Read full review →

From $59/mo + membership

Get started →

altRX vs MEDVi: FAQ

For compounded semaglutide, altRX costs less: about $2,520 less a year at the standing price, with no prepay or separate membership listed (not a first-month promo). See Costs & coverage above for each medication side by side.
altRX scores higher overall at 7.4/10 versus 7.1/10, and is particularly strong for low-cost compounded GLP-1s with brand-name Zepbound, Wegovy and Ozempic as options. That said, MEDVi is a better fit if you want switching between compounded and brand-name GLP-1 through one provider.
Both altRX and MEDVi are affiliate partners, meaning we may earn a commission if you sign up through our links. Our scores are assigned editorially using the same six-dimension framework for every provider — partnership never changes a score. We disclose every commercial relationship.
altRX: $89, about $1,068 a year. MEDVi: $299, about $3,588 a year; first month $179. altRX costs about $2,520 less a year at these prices.
altRX doesn't publish a state list. MEDVi publishes 48 states. Where a list isn't published, confirm your state during sign-up before paying.
altRX: cancel anytime — yes; minimum commitment — Single-month and multi-month plans; multi-month plans are a single, non-refundable purchase for the full term; early-cancellation fee — not disclosed. MEDVi: cancel anytime — not disclosed; minimum commitment — Membership; early-cancellation fee — not disclosed. Check the provider's own terms before you buy.

Key terms, explained

New to GLP-1s? Tap any term for a quick, plain-English definition.

Continue exploring altRX and MEDVi head-to-heads in the same category.

Or see the full category ranking.

Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.